Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea.

Yum, Ho-Kee; Kim, Hak-Ryul; Soo Chang, Yoon; Shin, Kyeong-Cheol; Kim, Song; Oh, Yeon-Mok

doi:10.4046/trd.2017.80.1.52

Public

Safety and Effectiveness of Indacaterol in Chronic Obstructive Pulmonary Disease Patients in South Korea.

Shared by NobleBlocks on Jan 1, 2017 • 12:00 AM UTC

Authors:

Ho-Kee Yum

Hak-Ryul Kim

Yoon Soo Chang

Abstract

BACKGROUND: Inhaled indacaterol (Onbrez Breezhaler), a long-acting β2-agonist, is approved in over 100 countries, including South Korea, as a once-daily bronchodilator for maintenance and treatment of chronic obstructive pulmonary disease (COPD). Here, we present an interim analysis of a post-market...

Subject

Bronchodilator Agents

Indacaterol

Pulmonary Disease

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!